Therefore, after we confirmed that PS1‐S170F iPSC‐derived neuron exhibited the typical AD pathological features, we performed a proof‐of‐concept experiment to demonstrate the suitability of our AD patient‐derived iPSC lines for candidate drug screening. The gene discussed is PSEN1; the disease is Alzheimer disease.